(Q28194690)
Statements
Randomized evaluation of the safety and efficacy of enoxaparin versus unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes receiving the glycoprotein IIb/IIIa inhibitor eptifibatide (English)
0 references
21 January 2003
0 references
107
0 references
2
0 references
238-44
0 references